GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +12.5% ·
Aktienfluss -10.9% ·
neue Nettopositionen +11.1%
— Formel
Eigentümerfragmentierung — mehr Halter, kleinere Gesamtbeteiligung
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 5.45M | -7.2% | $166.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.85M | -52.1% | $148.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (passiv) | 2.85M | — | $87.04M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 2.82M | 0.0% | $86.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 2.82M | 0.0% | $86.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 1.89M | +38.5% | $57.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 1.48M | +348.5% | $45.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.48M | +348.5% | $45.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | ARK Investment Management ✦ | 1.44M | -4.8% | $43.99M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 1.23M | +87.6% | $37.48M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Norges Bank ✦ (passiv) | 1.19M | +1.1% | $36.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 873.08K | Neu | $26.67M | 0.1% | New | 1 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 503.10K | +14.8% | $15.37M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 279.80K | +392.6% | $8.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 96.40K | -88.6% | $2.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 45.70K | +267.5% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 45.70K | +267.5% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 45.70K | +267.5% | $1.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | PRIMECAP Management ✦ | 43.69K | -34.0% | $1.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 32.09K | Neu | $980,197 | 0.0% | New | 1 | SEC ↗ |
| 27 | Bridgewater Associates ✦ | 12.54K | -30.9% | $383,219 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | Gotham Asset Management ✦ | 7.82K | -48.5% | $238,932 | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $26.67M | 0.1% |
| Marshall Wace | $980,197 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 481 Inhaber, 137.05M Anteile, $11.53B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer, Director · 20.89K Ant. · $3.53M
Officer, Director · 7.59K Ant. · $1.29M
Officer, Director · 9.02K Ant. · $1.52M
Director · 116 Ant. · $18,148
Officer · 13.25K Ant. · $2.20M
Officer · 3.70K Ant. · $605,286
Officer · 9.93K Ant. · $1.63M
Officer · 19.01K Ant. · $3.14M
Officer · 400 Ant. · $67,168
Officer · 3.46K Ant. · $579,639
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik